Foros de Conocimiento
medtronic PRODUCTOS
boston_scientific PRODUCTOS
TERUMO PRODUCTOS
Biotronik PRODUCTOS
Sirtex PRODUCTOS
Striker Neurovascular PRODUCTOS
BIOSENSORS PRODUCTOS

ESTUDIOS


01 enero 2016

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Outcomes of One straight-line flow with and without pedal arch in patients with critical limb ischemia

Akihiro Higashimori MD1,*, Osamu Iida MD2, Yasutaka Yamauchi MD3, Daizo Kawasaki MD4, Masato Nakamura MD, PhD5, Yoshimitsu Soga MD6, Kan Zen MD7, Yoshiaki Yokoi MD, PhD, FSCAI, FJCC1 andon behalf of the OLIVE Investigators

Objectives: This study aimed to compare the outcomes of revascularization strategies for patients with critical limb ischemia (CLI) whereby single vessel run off to the foot was established with or without flow into a patent pedal arch.

08 septiembre 2015

CIRCULATION. Epidemiology and Prevention. Population-Based Study of Incidence, Risk Factors, Outcome, and Prognosis of Ischemic Peripheral Arterial Events

Dominic P.J. Howard, DPhil; Amitava Banerjee, DPhil; Jack F. Fairhead, MA; Linda Hands, FRCS; Louise E. Silver, DPhil; Peter M. Rothwell, FMedSci; on behalf of the Oxford Vascular Study

Background: There are few published data on the incidence and long-term outcomes of critical limb ischemia, acute limb ischemia, or acute visceral ischemia with which to inform health service planning, to monitor prevention, and to enable risk prediction.

11 septiembre 2015

CIRCULATION. Health Services and Outcomes Research. The Contemporary Safety and Effectiveness of Lower Extremity Bypass Surgery and Peripheral Endovascular Interventions in the Treatment of Symptomatic Peripheral Arterial Disease

Thomas T. Tsai, MD, MSc; Thomas F. Rehring, MD; R. Kevin Rogers, MD, MS; Susan M. Shetterly, MS; Nicole M. Wagner, MS; Rajan Gupta, MD; Omid Jazaeri, MD; Nasim Hedayati, MD; W. Schuyler Jones, MD; Manesh R. Patel, MD; P. Michael Ho, MD, PhD; Alan S. Go, MD; David J. Magid, MD, MPH

Background: Treatment for symptomatic peripheral artery disease includes lower extremity bypass surgery (LEB) and peripheral endovascular interventions (PVIs); however, limited comparative effectiveness data exist between the 2 therapies. We assessed the safety and effectiveness of LEB and PVI in patients with symptomatic claudication and critical limb ischemia.

01 enero 2016

INTERNATIONAL JOURNAL OF CARDIOLOGY. C-reactive protein predicts aortic aneurysmal disease progression after endovascular repair

Joaquin De Haro, Silvia Bleda, Francisco Acin

Objectives: This study aims to investigate the prognostic significance of the rate of variation of C-reactive protein (CRP) levels as a predictor of aneurysmal sac and neck expansion and, therefore, of aneurysm disease progression, in patients undergoing endovascular aneurysm repair (EVAR) in the absence of endoleaks.

01 diciembre 2014

JACC: CARDIOVASCULAR INTERVENTIONS. Two-Year Life Expectancy in Patients With Critical Limb Ischemia

Yoshimitsu Soga, MD∗; Osamu Iida, MD†; Mitsuyoshi Takahaera, MD‡; Keisuke Hirano, MD§; Kenji Suzuki, MD‖; Daizo Kawasaki, MD¶; Yusuke Miyashita, MD#; Taketsugu Tsuchiya, MD∗∗

Objectives: This study sought to estimate the 2-year life expectancy (2YLE) (estimated survival rate >50% at 2 years) in patients with critical limb ischemia (CLI) using the risk score based on predictors of all-cause mortality within 2 years.

01 julio 2014

CIRCULATION: CARDIOVASCULAR INTERVENTIONS. Personalized Approach to Revascularization of Critical Limb Ischemia

Mehdi H. Shishehbor, DO, PhD, MPH and Grant W. Reed, MD

Critical limb ischemia (CLI) is a complex disease process that often occurs alongside numerous comorbidities, and as such requires a personalized, multidisciplinary treatment approach in every patient. Patient outcomes are generally poor and there remains a lack of consensus on the optimal revascularization strategy in individuals with CLI.

19 agosto 2014

CIRCULATION: CARDIOVASCULAR INTERVENTIONS. Peripheral Vascular Disease. Effect of Single Tibial Artery Revascularization on Microcirculation in the Setting of Critical Limb Ischemia

Osami Kawarada, MD, Satoshi Yasuda, MD, PhD, Kunihiro Nishimura, MD, PhD, Shingo Sakamoto, MD, Miyuki Noguchi, RN, Yasuomi Takahi, MD, PhD, Koichiro Harada, MD, PhD, Masaharu Ishihara, MD, PhD and Hisao Ogawa, MD, PhD

Background: Benefits of 2-dimensional (2D) angiosome-oriented infrapopliteal revascularization remain controversial. The aim of this retrospective study was to clarify the effect of single tibial artery revascularization on the dorsal and plantar microcirculation of critically ischemic limbs based on skin perfusion pressure (SPP).

01 julio 2015

EUROPEAN JOURNAL OF VASCULAR & ENDOVASCULAR SURGERY. Editor´s Choice – Minimizing Radiation Exposure During Endovascular Procedures: Basic Knowledge, Literature Review, and Reporting Standards

A. Hertault, B. Maurel, M. Midulla, C. Bordier, L. Desponds, M. Saeed Kilani, J. Sobocinski, S. Haulon

Context: Endovascular procedures, requiring X-ray guidance, are commonly performed in vascular surgery. X-ray exposure is associated with biological risks for both patients and physicians. Medical X-ray use must follow “as low as reasonably achievable” (ALARA) principles, which aim at using the lowest radiation exposure to achieve a procedure safely. This is underlined by European and international recommendations that also suggest that adequate theoretical and practical training is mandatory during the initial education of physicians. However, the content of this education and professional practices vary widely from one country to another.

01 agosto 2015

EUROPEAN JOURNAL OF VASCULAR & ENDOVASCULAR SURGERY. Editor´s Choice – Thirty day Outcomes and Costs of Fenestrated and Branched Stent Grafts versus Open Repair for Complex Aortic Aneurysms

M. Michel, J.-P. Becquemind, M.-C. Clémentd, J. Marzelle, C. Quelen, I. Durand-Zaleski on behalf of the WINDOW Trial Participantse

Objective: To compare 30 day outcomes and costs of fenestrated and branched stent grafts (f/b EVAR) and open surgery (OSR) for the treatment of complex abdominal aortic aneurysms (AAA) and thoraco-abdominal aortic aneurysms (TAAA).

01 septiembre 2015

EUROPEAN JOURNAL OF VASCULAR & ENDOVASCULAR SURGERY. Editor´s Choice – ECAR (Endovasculaire ou Chirurgie dans les Anévrysmes aorto-iliaques Rompus): A French Randomized Controlled Trial of Endovascular Versus Open Surgical Repair of Ruptured Aorto-iliac Aneurysms

P. Desgranges, H. Kobeiter, S. Katsahian, M. Bouffi, P. Gouny, J.-P. Favre, J.M. Alsac, J. Sobocinski, P. Julia, Y. Alimi, E. Steinmetz, S. Haulon, P. Alric, L. Canaud, Y. Castier, E. Jean-Baptiste, R. Hassen-Khodja, P. Lermusiaux, P. Feugier, L. Destrieux-Garnier, A. Charles-Nelson, J. Marzelle, M. Majewski, A. Bourmaud, J.-P. Becquemin the ECAR Investigators

Objectives/Background: ECAR (Endovasculaire ou Chirurgie dans les Anévrysmes aorto-iliaques Rompus) is a prospective multicentre randomized controlled trial including consecutive patients with ruptured aorto-iliac aneurysms (rAIA) eligible for treatment by either endovascular (EVAR) or open surgical repair (OSR). Inclusion criteria were hemodynamic stability and computed tomography scan demonstrating aorto-iliac rupture.

01 noviembre 2015

EUROPEAN JOURNAL OF VASCULAR & ENDOVASCULAR SURGERY. Editor´s Choice – First Results of the Covered Endovascular Reconstruction of the Aortic Bifurcation (CERAB) Technique for Aortoiliac Occlusive Disease

F.A.B. Grimme, P.C.J.M. Goverde, P.J.E.M. Verbruggen, C.J. Zeebregts, M.M.P.J. Reijnen

Objective: In this study the first results are presented of a new endovascular technique using covered stents to reconstruct the aortic bifurcation in patients with aortoiliac occlusive disease. With the “Covered Endovascular Reconstruction of the Aortic Bifurcation” (CERAB) technique, the anatomy and physiology of the aortic bifurcation is mimicked.

01 octubre 2015

ENDOVASCULAR TODAY. Where Intervention Meets Oncology

John A. Kaufman, MD, MS, Guest Chief Medical Editor

I know what you are thinking: “What does oncology have to do with Endovascular Today?” The topics within these pages usually pertain to vascular diseases and the many issues surrounding them. Even the name of the publication indicates a vascular orientation. So why this foray into cancer?

01 octubre 2015

ENDOVASCULAR TODAY. Hepatoma: Image-Guided Treatment Options in 2016

Jeffrey R. Ramkaransingh, MD, and Matthew S. Johnson, MD, FSIR

Globally, primary liver cancer is the sixth most common cancer and is the second highest cause of cancer mortality.1 Hepatoma, or hepatocellular carcinoma (HCC), accounts for approximately 80% of primary liver tumors. Major risk factors for the development of HCC include hepatitis B infection, hepatitis C infection, cirrhosis, heavy alcohol consumption, and nonalcoholic steatohepatitis.2

01 octubre 2015

ENDOVASCULAR TODAY. Transarterial Treatment of Liver Metastatic Neuroendocrine Tumors

Christopher Molvar, MD; Andrew Lipnik, MD; Daniel Brown, MD; and Robert Lewandowski, MD

Neuroendocrine tumors (NETs) arise from neural and endocrine organs throughout the body, most commonly the gastrointestinal system and pancreas. The World Health Organization classifies well-differentiated gastroenteropancreatic NETs into low grade and intermediate grade, and most poorly differentiated tumors are considered high grade, based on mitotic count/Ki-67 proliferative index.1 Indolent and well-differentiated tumors of the digestive system are traditionally called carcinoid and pancreatic neuroendocrine (islet cell) tumors. Well-differentiated tumors are often indolent, even in the setting of metastatic disease, and thus, are labeled “cancers in slow motion.”2

Utilizamos cookies propias para el correcto funcionamiento del sitio web y mejorar nuestros servicios. Pulse el botón Aceptar todas para aceptar su uso. Puede cambiar la configuración u obtener más información en nuestra Política de cookies o pulsando Modificar configuración.